Infant Bacterial Therapeutics AB (9IB.F) Q2 2026 Earnings

May 6Confirmed
Q4 2025
Q1 2026
Q2 2026
-0.13
-0.11
-0.09
-0.07

Details

Expected EPS
-0.12623053199999998
Actual EPS
N/A
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Infant Bacterial Therapeutics AB⁩ (⁦9IB.F⁩) will report earnings of for ⁦Q2 2026⁩ on May 6, 2026.

0 Comments

Share your thoughts